Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 12(1): 444, 2022 01 10.
Artículo en Inglés | MEDLINE | ID: mdl-35013505

RESUMEN

Although islet transplantation (ITx) is a promising therapy for severe diabetes mellitus, further advancements are necessary. Adiponectin, an adipokine that regulates lipid and glucose metabolism, exerts favorable effects on islets, such as reinforcement of the insulin-releasing function. This study evaluated the possibility of adiponectin use to improve ITx outcomes. We treated mouse islets with 10 µg/mL recombinant mouse adiponectin by overnight culture and then assessed the insulin-releasing, angiogenic, and adhesion functions of the islets. Furthermore, 80 syngeneic islet equivalents with or without adiponectin treatment were transplanted into the renal subcapsular space of diabetic mice. In in vitro assessment, released insulin at high glucose stimulation, insulin content, and expressions of vascular endothelial growth factor and integrin ß1 were improved in adiponectin-treated islets. Furthermore, adiponectin treatment improved the therapeutic effect of ITx on blood glucose levels and promoted angiogenesis of the transplanted islets. However, the therapeutic effect was not pronounced in glucose tolerance test results. In conclusion, adiponectin treatment had preferable effects in the insulin-releasing, angiogenic, and adhesion functions of islets and contributed to the improvement of ITx. The future use of adiponectin treatment in clinical settings to improve ITx outcomes should be investigated.


Asunto(s)
Adiponectina/uso terapéutico , Trasplante de Islotes Pancreáticos , Islotes Pancreáticos/efectos de los fármacos , Adiponectina/farmacología , Animales , Adhesión Celular/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Secreción de Insulina/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Neovascularización Fisiológica/efectos de los fármacos
2.
Pharm Dev Technol ; 21(6): 737-48, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26024240

RESUMEN

Alpha lipoic acid (ALA), an active substance in anti-aging products and dietary supplements, need to be masked with an edible polymer to obscure its unpleasant taste. However, the high viscosity of the ALA molecules prevents them from forming microcomposites with masking materials even in supercritical carbon dioxide (scCO2). Therefore, the purpose of this study was to investigate and develop a novel production method for microcomposite particles for ALA in hydrogenated colza oil (HCO). Microcomposite particles of ALA/HCO were prepared by using a novel gas-saturated solution (PGSS) process in which the solid-dispersion method is used along with stepwise temperature control (PGSS-STC). Its high viscosity prevents the formation of microcomposites in the conventional PGSS process even under strong agitation. Here, we disperse the solid particles of ALA and HCO in scCO2 at low temperatures and change the temperature stepwise in order to mix the melted ALA and HCO in scCO2. As a result, a homogeneous dispersion of the droplets of ALA in melted HCO saturated with CO2 is obtained at high temperatures. After the rapid expansion of the saturated solution through a nozzle, microcomposite particles of ALA/HCO several micrometers in diameter are obtained.


Asunto(s)
Dióxido de Carbono/química , Química Farmacéutica/métodos , Microesferas , Ácido Tióctico/síntesis química , Cromatografía con Fluido Supercrítico/métodos , Hidrogenación , Tamaño de la Partícula , Soluciones Farmacéuticas/análisis , Soluciones Farmacéuticas/síntesis química , Soluciones Farmacéuticas/farmacocinética , Ácido Tióctico/análisis , Ácido Tióctico/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA